Ozden Rabia Gurses

CIK 00018148833 companiesREDWOOD CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001814883

Recent Transactions

31 trades

Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−44,010→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−48,750→ 0 total
Disposition from Tender
Adverum Biotechnologies, Inc.
Common Stock - Restricted Stock Units
2025-12-09−8,125→ 0 total
Award
Adverum Biotechnologies, Inc.
Common Stock - Performance Stock Units
2025-12-09+85,000→ 85,000 total
Disposition from Tender
Adverum Biotechnologies, Inc.
Common Stock - Performance Stock Units
2025-12-09−85,000→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−8,000→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−4,000→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−85,000→ 0 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+8,000→ 8,000 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17−8,000→ 0 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+4,000→ 4,000 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17−4,000→ 0 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-02-25+48,750→ 48,750 total
Award
Adverum Biotechnologies, Inc.
Common Stock
2025-02-25+8,125→ 8,125 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2024-08-02+44,010→ 44,010 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2024-06-17+85,000→ 85,000 total
Sale
OCULAR THERAPEUTIX, INC$OCUL
Common Stock
2024-02-05$4.86/sh+6,346→ 153,054 total
Award
OCULAR THERAPEUTIX, INC$OCUL
Stock Option (Right to Buy)
2024-02-03+200,000→ 200,000 total
Award
OCULAR THERAPEUTIX, INC$OCUL
Common Stock
2024-02-03+66,633→ 159,400 total
Sale
OCULAR THERAPEUTIX, INC$OCUL
Common Stock
2024-01-31$4.95/sh−7,764→ 92,767 total
Sale
OCULAR THERAPEUTIX, INC$OCUL
Common Stock
2023-07-07$4.93/sh−832→ 100,531 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2023-06-09+40,000→ 40,000 total
Sale
OCULAR THERAPEUTIX, INC$OCUL
Common Stock
2023-02-06$4.24/sh−6,416→ 101,363 total
Award
OCULAR THERAPEUTIX, INC$OCUL
Stock Option (Right to Buy)
2023-01-30+50,000→ 50,000 total
Award
OCULAR THERAPEUTIX, INC$OCUL
Common Stock
2023-01-30+55,556→ 107,779 total
Award
OCULAR THERAPEUTIX, INC$OCUL
Stock Option (Right to Buy)
2023-01-30+166,667→ 166,667 total
Award
OCULAR THERAPEUTIX, INC$OCUL
Stock Option (Right to Buy)
2022-07-14+10,000→ 10,000 total
Award
OCULAR THERAPEUTIX, INC$OCUL
Stock Option (Right to Buy)
2022-07-01+20,000→ 40,000 total
Award
OCULAR THERAPEUTIX, INC$OCUL
Stock Option (Right to Buy)
2022-07-01+20,000→ 20,000 total
Award
OCULAR THERAPEUTIX, INC$OCUL
Common Stock
2022-07-01+6,667→ 52,223 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2022-03-17+80,000→ 80,000 total

Companies

Recent Filings

Address

C/O ADVERUM BIOTECHNOLOGIES, INC. 100 CARDINAL WAY

REDWOOD CITY, CA, 94063

View on SEC.gov